1. Home
  2. PSIG vs EQ Comparison

PSIG vs EQ Comparison

Compare PSIG & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSIG
  • EQ
  • Stock Information
  • Founded
  • PSIG 1993
  • EQ 2017
  • Country
  • PSIG Hong Kong
  • EQ United States
  • Employees
  • PSIG N/A
  • EQ N/A
  • Industry
  • PSIG
  • EQ Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSIG
  • EQ Health Care
  • Exchange
  • PSIG NYSE
  • EQ Nasdaq
  • Market Cap
  • PSIG 9.3M
  • EQ 13.1M
  • IPO Year
  • PSIG N/A
  • EQ 2018
  • Fundamental
  • Price
  • PSIG $0.35
  • EQ $0.38
  • Analyst Decision
  • PSIG
  • EQ Buy
  • Analyst Count
  • PSIG 0
  • EQ 3
  • Target Price
  • PSIG N/A
  • EQ $3.00
  • AVG Volume (30 Days)
  • PSIG 87.6K
  • EQ 576.7K
  • Earning Date
  • PSIG 08-08-2025
  • EQ 08-07-2025
  • Dividend Yield
  • PSIG N/A
  • EQ N/A
  • EPS Growth
  • PSIG N/A
  • EQ N/A
  • EPS
  • PSIG N/A
  • EQ N/A
  • Revenue
  • PSIG $87,166,469.00
  • EQ $30,406,000.00
  • Revenue This Year
  • PSIG N/A
  • EQ N/A
  • Revenue Next Year
  • PSIG N/A
  • EQ N/A
  • P/E Ratio
  • PSIG N/A
  • EQ N/A
  • Revenue Growth
  • PSIG N/A
  • EQ N/A
  • 52 Week Low
  • PSIG $0.27
  • EQ $0.27
  • 52 Week High
  • PSIG $2.82
  • EQ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • PSIG N/A
  • EQ 50.77
  • Support Level
  • PSIG N/A
  • EQ $0.36
  • Resistance Level
  • PSIG N/A
  • EQ $0.47
  • Average True Range (ATR)
  • PSIG 0.00
  • EQ 0.05
  • MACD
  • PSIG 0.00
  • EQ 0.00
  • Stochastic Oscillator
  • PSIG 0.00
  • EQ 39.00

About PSIG PS INTERNATIONAL GROUP LTD

PS International Group Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports, and local transportation and warehousing-related services such as repackaging, labeling, palletization, preparation of shipping documentation, arrangement of customs clearance, and warehousing to meet the requirements of customers. The company generates the majority of its revenue from Air freight services.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: